Get started
Author

John O. Praag

Observed names: J. O. Praag, J. Praag, J.O. Praag, John O Praag, John Praag, Praag, John
OpenAlex ID: A5040740354
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
2014 · Ben J Slotman, Harm van Tinteren, et al. · The Lancet · 608
PDF
Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome
2009 · Noëlle C. van der Voort van Zyp, Jean-Briac Prévost, et al. · Radiotherapy and Oncology · 217
Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results
2006 · J. J. Nuyttens, J.-B. Prévost, et al. · Acta Oncologica · 137
PDF
Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non–Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study
2018 · Dirk De Ruysscher, Anne-Marie C. Dingemans, et al. · Journal of Clinical Oncology · 122
Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors
2012 · Joost J. Nuyttens, Noelle C. van der Voort van Zyp, et al. · Radiotherapy and Oncology · 103
Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial
2017 · Ben J. Slotman, Corinne Faivre-Finn, et al. · Lung Cancer · 95
PDF
Radiotherapy for extensive stage small-cell lung cancer – Authors' reply
2015 · Ben J Slotman, Harm van Tinteren, et al. · The Lancet · 52
PDF
HDR prostate monotherapy – Dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging
2007 · Yvette Seppenwoolde, Inger-Karine Kolkman-Deurloo, et al. · Radiotherapy and Oncology · 38
High-Dose-Rate Brachytherapy and External-Beam Radiotherapy for Hormone-Naïve Low- and Intermediate-Risk Prostate Cancer: A 7-Year Experience
2012 · Shafak Aluwini, Peter H. van Rooij, et al. · International Journal of Radiation Oncology*Biology*Physics · 32
Four-dimensional Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer: A Comparative Planning Study
2008 · Jean-Briac Prévost, Peter Voet, et al. · Technology in Cancer Research & Treatment · 24
Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer
2015 · Shafak Aluwini, Wendy M.H. Busser, et al. · Radiotherapy and Oncology · 21
Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study
2019 · W.J.A. Witlox, B.L.T. Ramaekers, et al. · Radiotherapy and Oncology · 20
PDF
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies
2010 · V. Surmont, E.F. Smit, et al. · Lung Cancer · 17
Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC
2022 · Simon A. Keek, Esma Kayan, et al. · Therapeutic Advances in Medical Oncology · 13
PDF
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
2020 · Sarah Baker, Katerina Bakunina, et al. · Radiation Oncology · 12
PDF
Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study
2023 · Haiyan Zeng, Lizza E.L. Hendriks, et al. · Radiotherapy and Oncology · 8
PDF
Optimal delineation of the clinical target volume for thymomas in the post-resection setting: A multi-center study
2021 · Florit Marcuse, Stephanie Peeters, et al. · Radiotherapy and Oncology · 7
PDF
Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study
2019 · W. J. A. Witlox, B. L. T. Ramaekers, et al. · Acta Oncologica · 6
PDF
To the Editor
2004 · J. van der Zee, M. van de Pol, et al. · Radiotherapy and Oncology · 4
127P Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?
2022 · L. Hendriks, S.A. Keek, et al. · Annals of Oncology · 3
Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy
2016 · B.J. Slotman, C. Faivre-Finn, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
International Multicenter Randomized Study on Thoracic Radiation Therapy (RT) in Extensive Stage Small Cell Lung Cancer (ES-SCLC): Patterns of Disease Recurrence
2014 · B.J. Slotman, C. Faivre-Finn, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
Randomized trial on thoracic radiotherapy (TRT) in extensive-stage small cell lung cancer.
2014 · Ben J. Slotman, Corinne Faivre-Finn, et al. · Journal of Clinical Oncology · 3
The effect of prophylactic cranial irradiation (PCI) for young stage III NSCLC patients: Subgroup analyses of the NVALT-11/DLCRG-02 study
2019 · W.J.A. Witlox, B. Ramaekers, et al. · Annals of Oncology · 2
PDF
MA 17.10 Toxicity Results from the Randomized Phase III NVALT-11 Study of Prophylactic Cranial Irradiation vs. Observation in Stage III NSCLC
2017 · D. De Ruysscher, A. Dingemans, et al. · Journal of Thoracic Oncology · 2
Works count: 46
Citation count: 1,556
H-index: 13
I10-index: 15
Year
Topic
Type